Brazil’s Immunization Agenda 2030 - Seeking to resume the path towards its achievement

February 10, 2023


Brazil’s Immunization Agenda 2030 - Seeking to resume the path towards its achievement

February 10, 2023

Marcio Zanetti

Country leader, Brazil

Marcio Zanetti is the country leader for Brazil at Economist Impact. He has extensive experience in management and research consulting for multinational corporations in the Latin American region. His areas of expertise are financial forecasting modelling, strategic due diligence, organisational impact assessment, strategic planning and development, market sizing and market entry strategy, investment analysis, and risk assessment. Marcio has deep knowledge of healthcare and financial markets. He has wide international exposure, having developed projects in Argentina, Brazil, Colombia, Italy, Mexico, Spain, and Ukraine. He has a BA in Marketing and holds an MBA from the William E. Simon Graduate School of Business Administration, University of Rochester, US. Marcio is fluent in Portuguese, English, and Spanish.

Marcio Zanetti é o country leader para o Brasil na Economist Impact. Ele tem larga experiência em consultoria de gestão e pesquisa para corporações multinacionais na região latino-americana. Suas áreas de especialidade são modelagem de projeção financeira, avaliação estratégica e avaliação de impacto organizacional, planejamento estratégico e desenvolvimento, dimensionamento de mercados e estratégia de entrada de mercado, análises de investimentos e avaliações de risco. Marcio tem conhecimento profundo em mercados de saúde e financeiro. Ele tem ampla exposição internacional, tendo desenvolvido projetos na Argentina, Brasil, Colômbia, Itália, México, Espanha e Uncrâna. Ele é formado em marketing e tem MBA pela William E. Simon Graduate School of Business Administration, University of Rochester, EUA. Marcio fala fluentemente Português, Inglês e Espanhol.

Marcio Zanetti es el gerente general para Brasil en la Economist Impact. Tiene una amplia experiencia en consultoría de gestión e investigación para empresas multinacionales en la región de América Latina. Sus áreas de especialización son la creación de modelos proyecciones financieras, el due dilligence estratégico y la evaluación del impacto organizacional, la planificación y desarrollo estratégicos, el dimensionamiento del mercado y la estrategia de entrada al mercado, el análisis de inversiones y la evaluación de riesgos. Marcio tiene un profundo conocimiento de los mercados de salud y financieros. Tiene una amplia exposición internacional, habiendo desarrollado proyectos en Argentina, Brasil, Colombia, Italia, México, España y Ucrania. Tiene una licenciatura en marketing y un MBA de William E. Simon Graduate School of Business Administration, University of Rochester, EE. UU. Marcio habla portugués, inglés y español.

Brazil has witnessed a consistent decrease in vaccine coverage from 2015 forward, which brought risks that the country could not meet the goals defined by the World Health Organization (WHO) through its Immunization Agenda 2030 (IA2030). Economist Impact held a roundtable meeting to discuss the topic and dive more deeply into gaps and opportunities to position Brazil for success.

Vaccine coverage in Brazil has decreased since 2015. Until the middle of the last decade, it was considered an example for other emerging countries, particularly those of Latin America. This fall has sparked concern among experts and public administrators, not only because of its consequences for the public health, but also because of its implication for the country’s commitments to UN’s Objectives for Sustainable Development for 2030. After all, Brazil is one of the WHO IA2030 signatory countries.

Economist Impact undertook this research to identify the causes for this recent fall and the challenges Brazil faces to resume its vaccine coverage, and to propose a set of actions that support Brazil to get back on track to achieve the goals set by IA2030.This report was built by analysing academic research, governmental documents at federal, state and municipal levels, and interviews with experts, many of whom are former and current public servants.

The National Immunization Programme (Programa Nacional de Imunização, or PNI) is one of the largest and more complex in the world, and faces several challenges, from its complex logistics to acquire, distribute and apply vaccines, the lack of specialized personnel fully dedicated to vaccination, to the challenges of implementing an integrated information system that allows the complete tracking down of the vaccines up to their delivery to the whole population.

Our main finding is that the greatest challenge is the difficulty of public administrators, working at federal, state and municipal levels, to completely visualise the needs of the population, including several specific groups, the vaccination process and the achieved results. This lack of transparency brings inefficiency to the strategic planning and decision process, since they rely on assumptions that may not be based on real facts. As a consequence, resource allocation also becomes inefficient, leading to investments in the vaccination activity that do not convert to efficient, equitable vaccination that would lead to the total elimination of communicable diseases.

In order to bring Brazil back on track to achieve the IA2030 proposed goals, we suggest that the following points should be addressed:

  • Implementation of a fully integrated tracking system to be used by all governmental entities, with qualified personnel to manage it who are appropriately incentivized;

  • Creation of capable teams fully dedicated to the vaccination activity;

  • Investments in infrastructure involved in the logistical process of vaccination in Brazil, including collaborative processes such as public-private partnership models;

  • Re-evaluation of the current formats of vaccination, including the increase of combined vaccines and reduction of multi-dose vials in order to reduce vaccine waste and increase vaccine efficiency;

  • These activities may require resources currently not available in the public sector. For this reason, the private sector involvement, whether through PPPs or joint collaboration for the creation of greater value added contracts for the county, should be taken into account.


Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week